Vaccinex, Inc. announced that Steve Cobourn, CPA has joined the company as chief financial officer and a member of the company's executive team. Steve will provide strategic and functional oversight of all finance and accounting activities for the company. Steve is a member of the American Institute of Public Accountants (AICPA), a Corporate Executive Board member of Accounting & Reporting, FP&A, and Shared Services Councils, and the PhRMA Accounting & Reporting Subcommittee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 USD | +30.58% | +25.74% | -27.05% |
05-16 | Earnings Flash (VCNX) VACCINEX Reports Q1 Revenue $104,000 | MT |
04-12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-27.05% | 10.74M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.09% | 21.96B | |
-9.68% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- VCNX Stock
- News Vaccinex, Inc.
- Vaccinex, Inc. Announces Joining of Steve Cobourn as Chief Financial Officer and Member of the it’s Executive Team